Do corticosteriods influence the disease course or mortality in Guillain - Barre' Syndrome?

Journal of Association of Physicians of India

Volumn 44, Issue 1, 1996, Pages 22-24

  Singh, N K ^a   Gupta, A ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; PLACEBO; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INDIA; MALE; MORTALITY; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INDIA; MALE; NEUROLOGIC EXAMINATION; PLACEBOS; POLYRADICULONEUROPATHY; PREDNISOLONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029685592     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Heller GL, DeJong RN. Treatment of the Gullain - Barre' Syndrome. Use of Corticotropin and Glucocorticoids. Arch Neurol 1963; 8 : 179-92.
2. McFarland HR, Heller GL, Arbor A. The Gullain - Barre disease complex. Arch Neurol 1996; 14 : 197-201.
3. Swick HM, McQuillen MP. The use of steroid in the treatment of idiopathic polyneuritis. Neurology 1976; 26 : 205-12.
4. Hughes RAC. Ineffectiveness of high - dose intravenous methyl prednisolone in acute polyneuropathy 1978; 1 : 750-3.
5. Hughes RAC. Ineffectiveness of high - dose intravenous methyl prednisolone in Guillain - Barre' Syndrome. Lancet 1991; 338 : 1142.
6. Guillain - Barre' Syndrome Steroid Trial Group. Double blind trial of intravenous methylprednisolone in Guillain - Barre' Syndrome. Lancet 1993; 341 : 586-90.
7. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain - Barre' syndrome. Ann Neurol 1990; 27 (Suppl) : 521-4.
8. Hartung HP, Schafer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathognesis of experimental allergic neuritis. Brain 1988; 111 : 1039-59.
9. Hughes RAC, Kadlubowski M, Hufshimdt A. Treatment of acute inflammatory polyneuropathy. Ann Neurol 1981; 9 (suppl) : 125-33.
10. Griffin JW, Stoll G, Li CY, Tyor W, Cornblath DR. Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 1990; 27 : 64-68.
11. Drachman DA, Paterson PY, Berlin BS et al. Immunosuppression and the Guillain - Barre' Syndrome. Arch Neurol 1970; 23: 385-93.
12. Klingon GH. The Gullain - Barre' Syndrome associated with cancer. Cancer 1965; 18 : 157-63.
13. French Co-operative Group on Plasma Exchange in Guillain - Barre' Syndrome : role of replacement fluids. Ann Neurol 1987; 22 : 753-6.
14. The Guillain - Barre' Syndrome Study Group. Plasma Exchange in Guillain - Barre' Syndrome. Neurology 1985; 35 : 1096-104.
15. Osterman PO, Fagius J, Lundemo G, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2 : 1296-99.
16. Van der Meche FGA, Schmitz PIM, Dutch Guillain - Barre' Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain - Barre' syndrome globulin and plasma exchange in Guillain - Barre' syndrome. N Engl J Med 1992; 326 : 1123-29.